Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo.

Fallarino F, Uyttenhove C, Boon T, Gajewski TF. Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo. J Immunol. 1996 Feb 01; 156(3):1095-100.

View in: PubMed

collapse authors with profiles